« Real Marine Combat Video Unedited | Main | Spanish Terror Cell Sent Cash To Pearl's Killers »

November 15, 2004

Adverse Reactions to Biological Modifiers

Topics: Clinical Pharmacology

Abstract Review From Current Opinion in Allergy and Clinical Immunology:

Newer biologic immunomodulators such as interferons, tumor necrosis factor α (TNFα) inhibitors, and monoclonal antibodies have been introduced into the management of various inflammatory conditions. This review addresses adverse responses to these agents.

Recent Findings: Both interferon-α and interferon-β have been associated with autoimmune phenomena. The ability of TNFα antagonists to cause significant adverse reactions appears to be substantial. These are either related to interference with TNFα activity or as consequence of the agents, either immunoglobulin or fusion protein, being recognized as foreign proteins, becoming themselves targets of an immune response.

Summary: Although advancing the management of inflammatory conditions, biologic modifiers are attended by significant concerns. Identification of at risk groups and careful selection of appropriate patients will minimize occurrence of adverse events.

Read More (Registration May Be Required)...

Posted by Hyscience at November 15, 2004 9:56 PM

Articles Related to Clinical Pharmacology:

• Britain tests first Cannabis related medicine for rheumatoid arthritis - Nov 13, 2005
• Experimental human monoclonal antibody shows striking benefit in patients with advanced melanoma - May 26, 2005
• Cystatin C May Push Creatinine Off Risk Radar - May 19, 2005
• Cancer Treatment Success Stuns Scientists - May 16, 2005
• Antibody, cancer drug combo shows promise against breast tumors - May 16, 2005
• USC researchers determine mechanism of action of motexafin gadolinium (Xcytrin) - May 02, 2005
• Herceptin® Combined With Chemotherapy Improves Disease-Free Survival for Patients With Early-Stage Breast Cancer - Apr 26, 2005
• Selenium will have critical role in prostate cancer treatment - Fox Chase Cancer Center - Apr 21, 2005
• Traditional Medicine Derivatives Kill Cancer Cells - Apr 20, 2005
• Compound from Chinese medicine shows promise in head and neck cancer, U-M study finds - Apr 19, 2005